José del R. Millán, PhD

José del R. Millán, PhD

Defitech Professor at EPFL

Dr. José del R. Millán joined the École Polytechnique Fédérale de Lausanne (EPFL) in 2009 as the first professor of the Center for Neuroprosthetics where he holds the Defitech Foundation Chair. He received a PhD in computer science from the Technical University of Catalonia, Barcelona, in 1992. Previously, he was a research scientist at the

Read More...

Joshua Kantrowitz, MD

Joshua Kantrowitz, MD

Assistant Professor of Psychiatry at NYSPI/Columbia University, and the Director of the Lieber Schizophrenia Research Clinic

Dr. Joshua Kantrowitz is an Assistant Professor of Psychiatry at NYSPI/Columbia University, and the Director of the Lieber Schizophrenia Research Clinic. He is the author of over 40 peer reviewed articles published in internationally recognized journals. His research work has been recognized with the Young Investigator Travel Award by the International Congress of Schizophrenia Research

Read More...

David A. Bennett, MD

David A. Bennett, MD

Director of the Rush Alzheimer's Disease Center

Dr. David A. Bennett Directs the Rush Alzheimer’s Disease Center at Rush University Medical Center, Chicago.  He is PI of several NIH grants including the Religious Orders Study and the Rush Memory and Aging Project, ongoing since the mid 1990s. His internationally recognized clinical-pathologic cohort studies have enrolled thousands of older persons all of whom

Read More...

Christoph Guger

Christoph Guger

Owner at g.tec neurotechnology USA, Inc.

Christoph Guger develops brain-computer interface technology for invasive and non-invasive applications ranging from rehabilitation, assessment to communication and control. He is active in several international research projects to develop this technology.  He is CEO at g.tec medical engineering GmbH, Guger Technologies OG,  g.tec neurotechnology USA Inc. and g.tec medical engineering Spain SL

Read More...

Scott Small, MD

Scott Small, MD

Columbia University Medical Center, Boris and Rose Katz Professor of Neurology, Director, Alzheimer's Disease Research Center

Scott A. Small M.D. is the Director of the Alzheimer’s Disease Research Center at Columbia University, where he is the Boris and Rose Katz Professor of Neurology. He is appointed in the Departments of Neurology, Radiology, and Psychiatry. With an expertise in Alzheimer’s disease and cognitive aging, Dr. Small’s research focuses on the hippocampus, a

Read More...

Niels Birbaumer, PhD

Niels Birbaumer, PhD

Senior Research Fellow, Wyss Center and Professor Emeritus and former Director, Institute of Medical Psychology and Behavioural Neurobiology, Eberhard-Karls Universität Tübingen

Niels Birbaumer is one of the leading figures in the history of brain-computer interfaces (BCI), which are direct communication devices between the brain and a computer. Birbaumer has been dealing with BCIs for as much as forty years. He believes in the power of BCIs, a power that is based on human imagination and is

Read More...

Robert T. Knight, MD

Robert T. Knight, MD

Professor of Psychology and Neuroscience UC Berkeley

Dr. Robert T. Knight, Bob M.D. serves as Chief Science Advisor at NeuroFocus, Inc. Dr. Knight is the Evan Rauch Professor of Neuroscience and Director of the Helen Wills Neuroscience Institute at UC Berkeley. Dr. Knight joined the Psychology Department at UC Berkeley in 1998 to develop a program in human neuroscience. Prior to moving

Read More...

Hedy Kober, PhD

Hedy Kober, PhD

Assistant Professor at Yale University

Dr. Kober runs the Clinical & Affective Neuroscience Laboratory through the Department of Psychiatry. Research in Yale’s Clinical and Affective Neuroscience Lab takes a cognitive-neuroscience approach to clinical questions, uses state-of-the-art neuroimaging methods, and organizes around a few interrelated themes: Craving, regulation of craving, substance use disorders, treatment for substance use disorders, neural mechanisms of change,

Read More...

Moshe Bar, PhD

Moshe Bar, PhD

Director of the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University

Moshe Bar is a cognitive neuroscientist, director of the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University, associate professor in psychiatry at Harvard Medical School, and associate professor in psychiatry and neuroscience at Massachusetts General Hospital. Prof. Bar had been using methods from cognitive psychology, psychophysics, computational neuroscience, psychiatry and human brain imaging to explore issues concerning human vision, contextual associations,

Read More...

Patrick Aebischer, MD

Patrick Aebischer, MD

Professor of Neuroscience at EPFL and EPFL Emeritus President 2000-2006. Chairman Novartis Venture Fund.

Patrick Aebischer was trained as an MD (1980) and a Neuroscientist (1983) at the Universities of Geneva and Fribourg in Switzerland. From 1984 to 1992, he worked at Brown University in Providence (Rhode Island, USA) as an Assistant and then Associate Professor of Medical Sciences. In the fall of 1992, he returned to Switzerland as

Read More...

Lucie Bruijn, PhD, MBA

Lucie Bruijn, PhD, MBA

Chief Scientist at The ALS Association

Lucie Bruijn, Ph.D. joined The ALS Association in January 2001 and is currently the Chief Scientist.  Prior to that Dr. Bruijn led a team at Bristol Myers Squibb developing in vitro and in vivo model systems for neurodegenerative disease. Realizing the potential of stem cell therapy for neurodegenerative diseases, her team worked with experts in

Read More...

Justin T Baker, MD PhD

Justin T Baker, MD PhD

Scientific Director of the Institute for Technology in Psychiatry, McLean Hospital

Justin Baker is Assistant Professor of Psychiatry at Harvard Medical School and Founding Scientific Director of the McLean Hospital Institute for Technology in Psychiatry. Dr. Baker joined the faculty of McLean in 2011, as Director of Functional Neuroimaging and Bioinformatics in the Schizophrenia and Bipolar Disorder Program, where his research employs a combination of large-scale

Read More...

Oren Shriki, PhD

Oren Shriki, PhD

Principal investigator, Computational Psychiatry Lab, Ben Gurion University

Dr. Oren Shriki completed undergraduate studies in physics and doctoral studies in computational neuroscience at the Hebrew University (Jerusalem, Israel). After a postdoctoral period at the National Institute of Mental Health (Bethesda, MD, USA), he established the computational psychiatry lab at Ben-Gurion University of the Negev (Beer-Sheva, Israel). Research in his lab uses mathematical analyses

Read More...

Sophia Vinogradov, MD

Sophia Vinogradov, MD

Professor and Head, Department of Psychiatry, University of Minnesota

Sophia Vinogradov, M.D. is Professor and Head of the Department of Psychiatry at the University of Minnesota. Previously she was Vice Chair, Department of Psychiatry and Professor of Psychiatry in Residence at UCSF. She was Associate Chief of Staff; Chief of Mental Health Service, at the San Francisco VA Medical Center. She was also Scientific Co-Director of the

Read More...

Jordan Amadio, MD, MBA

Jordan Amadio, MD, MBA

Co-Founder and Partner, NeuroLaunch, Chief Resident Physician in Neurosurgery, Emory University

Jordan Amadio, M.D., M.B.A. is Chief Resident Physician in Neurosurgery at Emory University in Atlanta and founder/managing partner of NeuroLaunch, the brain technology venture accelerator. In the past 2 years, NeuroLaunch has invested in 11 neuroscience companies, onboarded over 150 global mentors, expanded to 5 countries, and facilitated success for over 60 startups participating in its programming. Dr. Amadio received

Read More...

Patrice L. (Tamar) Weiss, PhD

Patrice L. (Tamar) Weiss, PhD

Director of the Laboratory for Innovations in Rehabilitation Technology (LIRT) at the University of Haifa

Prof. Patrice L. (Tamar) Weiss directs the Laboratory for Innovations in Rehabilitation Technology (LIRT) at the University of Haifa where she and her team develop and evaluate novel virtual environments, haptic interfaces, co-located and online technologies to explore the effect of individual and collaborative rehabilitation. Rehabilitation and special education populations of interest include stroke, spinal

Read More...

Ofer Sharon, MD

Ofer Sharon, MD

Co-founder and President Valera Health Inc.

Dr. Sharon is a physician and entrepreneur with extensive experience in both clinical and commercial product development for startups in health tech, biotech, and medical devices. As the former Medical Director for Merck Israel, Ofer founded a big data research collaboration between the pharmaceutical industry and a large payer. Ofer‘s His main fields of interest include

Read More...

Michal Rosen-Zvi, PhD

Michal Rosen-Zvi, PhD

Director for Health Informatics at IBM Research

Dr. Rosen-Zvi is the Director for Health Informatics at IBM Research. She also heads the Health Informatics Department at IBM Research, Haifa. She holds a PhD in Physics and submitted her thesis entitled “Learning from examples in complex networks” in 2002. In the three years that followed she conducted postdoctoral studies in the area of

Read More...

Ralph Laufer, PhD

Ralph Laufer, PhD

Senior Vice President and Head of Discovery and Product Development (DPD) at Teva Pharmaceuticals

  Ralph has 20+ years’ experience in the pharma industry, much of it as Head of Pharmacology at IRBM, the Rome site of Merck Research Laboratories. For his role in the discovery of IsentressTM, first-in-class inhibitor of HIV integrase and winner of the Prix Galien USA 2008 as best pharmaceutical agent, Ralph received the American Chemical Society Heroes of

Read More...

Tetsu Maruyama, PhD

Tetsu Maruyama, PhD

Chief Scientific Officer for the Dementia Discovery Fund (DDF)

Tetsu’s background is in neuroscience, having received his PhD from Stanford University and conducted post-doctoral research at Yale University.  After a 15-year academic career with faculty positions at the University of Minnesota in the US and Cardiff University in the UK, Tetsu moved to industry, first at Merck Sharpe and Dohme’s Neuroscience Research Centre in

Read More...

Ronen Gadot

Ronen Gadot

CEO, ElMindA

Recognizing the significance of better understanding brain function for improving the lives of millions affected by neuro-psychiatric disorders, Ronen joined ElMindA’s board as an investor in 2006, and soon thereafter became the company’s CEO.  Prior to his business career, Ronen’s track record of excellence began with an eight-year service as an F-16 fighter pilot and

Read More...

Anat Naschitz

Anat Naschitz

Managing Director at OrbiMed

Anat Naschitz is a Managing Director at OrbiMed, a preeminent global healthcare investment firm with ~$15 billion under management across public and private asset classes. The firm covers the entire healthcare spectrum, investing in biopharmaceuticals, medical devices and digital health. Anat has over 20 years of healthcare experience, and currently serves on the boards of

Read More...

John Isaac, PhD

John Isaac, PhD

Senior Director, Neuroscience External Innovation at the Johnson & Johnson Innovation Centre

John joined Johnson & Johnson in September 2016. In this role John uses his drug discovery and scientific experience to identify and advance external opportunities in the areas of Alzheimer’s Disease and Mood Disorders. Prior to joining Johnson & Johnson, since November 2014, John was Head of Neuroscience and Mental Health at the Wellcome Trust. 

Read More...

David L. Hankin, JD

David L. Hankin, JD

CEO of the Alfred Mann Foundation for Scientific Research (AMF)

David L. Hankin is the Chief Executive Officer of the Alfred Mann Foundation for Scientific Research (AMF), a not-for- profit organization founded by healthcare legend Alfred E. Mann in 1985. Reporting to AMF’s Board of  Directors, Hankin has P&L responsibility and is charged with setting the overall vision for AMF. Prior to this 2007 appointment, Mr. Hankin served

Read More...

Michael Merzenich, PhD

Michael Merzenich, PhD

Professor Emeritus, UCSF, Co-founder and CSO, Posit Science

Dr. Merzenich is the brain behind BrainHQ and the author of Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life. For nearly five decades, he has been a leading pioneer in brain plasticity research. As co-founder and Chief Scientific Officer of Posit Science, Michael Merzenich heads the company’s science team. Dr. Merzenich

Read More...

Varda Shalev, MD

Varda Shalev, MD

Head of the Maccabi Institute for Research & Innovation (Maccabitech)

Prof. Varda Shalev, MD MPH, is the head of the Maccabi Institute for Research & Innovation (Maccabitech), the executive director of Maccabi-Kahn Institute of Health Data Science, and a faculty member at the Tel-Aviv University School of Public Health (TAU SPH). Side by side to here senior level roles, Prof. Shalev is an active primary

Read More...

Mor Nahum, PhD

Mor Nahum, PhD

Faculty Member, School of OT, Hebrew University of Jerusalem

Dr. Nahum completed her PhD at the Interdisciplinary Center for Neural Computation at the Hebrew University in 2009. In 2009 she joined Brain Plasticity Institute (BPI) as a senior scientist, and led project involving social cognitive training in schizophrenia and autism. In 2011 she started her post-doctoral tenure at UC Berkeley, where she studied the

Read More...

Jesse M. Cedarbaum MD

Jesse M. Cedarbaum MD

Vice President, Parkinson’s Disease and Movement Disorders, Biogen

Dr. Cedarbaum received his B.A. and M.A. from Stanford University and his M.D. from Yale University. He completed his internship and residency in Internal Medicine at the University of Chicago Hospitals and Clinics and his Neurology residency at New York Hospital-Cornell Medical Center. He served on the faculty of Cornell Medical College and as Director

Read More...

Danielle A. Schlosser, PhD

Danielle A. Schlosser, PhD

Lead Clinical Research Scientist at Verily Life Sciences

Danielle’s work at Verily is focused on how we might use technology to transform mental health care through proactive and precision medicine approaches. Prior to joining Verily, she was an Assistant Professor of Psychiatry at the University of California, San Francisco. The goal of her research program was to design, develop, and investigate neuroscience-informed digital health interventions

Read More...

Eugenii (Ilan) Rabiner, MD

Eugenii (Ilan) Rabiner, MD

Chief Medical Officer at Imanova Ltd,

Eugenii (Ilan) Rabiner FCPsych SA. is the Head or Imaging Applications and Chief Medical Officer at Imanova Ltd, an imaging centre specializing in translational molecular research designed to optimize early phase drug development. He is also a Reader in Molecular Neuroimaging at the Centre for Neuroimaging Scieces, Institute of Psychiatry, Psychology and Neuroscience of King’s

Read More...

John Mann, MD

John Mann, MD

Professor of Translational Neuroscience at Columbia University, and Director, Molecular Imaging and Neuropathology Division at the New York State Psychiatric Institute

John Mann is The Paul Janssen Professor of Translational Neuroscience (in Psychiatry and in Radiology) at Columbia University and Director, Molecular Imaging and Neuropathology Division at the New York State Psychiatric Institute. He is a Past President of the Society of Biological Psychiatry, the International Academy of Suicide Research and the American Foundation for Suicide

Read More...

Daniel Javitt, MD

Daniel Javitt, MD

Professor of Psychiatry and Neuroscience at Columbia University College of Physicians and Surgeons

Dr. Javitt is Professor of Psychiatry and Neuroscience at Columbia University College of Physicians and Surgeons where he directs the Division of Experimental Therapeutics.  In addition, he serves as Director of Schizophrenia Research at Nathan Kline Institute for Psychiatric Research, a New York State Office of Mental Health-supported research facility.   Dr. Javitt received his

Read More...

Shekhar Saxena, MD

Shekhar Saxena, MD

Director of the Department of Mental Health and Substance Abuse (MSD) at WHO

Dr. Shekhar Saxena, Director of the Department of Mental Health and Substance Abuse (MSD) at WHO’s Headquarters Office, is the joint leader of the Mental Health Innovation Network. Dr Saxena is a psychiatrist with about 30 years of experience in research and program management, service delivery and information systems in the areas of mental health, especially

Read More...

Jonathan Javitt, MD

Jonathan Javitt, MD

Founder, Chairman, and CEO of NeuroRx, Inc.

A physician with a background in drug development, information technology, health economics, outcomes research, and public health. Dr. Javitt is currently Founder, Chairman, and CEO of NeuroRx, Inc. Founder of health information technology companies that have merged with Siemens, Inc., United Health Group, Inc., and Aetna, Inc. Presidential Appointee in the Bush and Clinton administrations.

Read More...

Avi Yaron

Avi Yaron

CEO at Joy Ventures

Avi Yaron, CEO of Joy Ventures, is a serial visionary entrepreneur, with extensive knowledge of all startup phases, from invention till international go-to-market, of various medical technologies, owning numerous technological & clinical patents. Joy Ventures is a privately-owned incubator, nurturing & investing long term in start-ups, within an exclusive emerging domain: scientifically-based cutting edge solutions

Read More...

Laurent Choppe, DVM

Laurent Choppe, DVM

Managing Partner Cukierman & Co. Life Sciences

Laurent has led Cukierman & Co. Life Sciences since 2008 and has been involved in more than 60 medtech and biotech corporate finance transactions and advisory assignments for the Cukierman group. His team works worldwide with venture-backed and middle market companies for fund raising, licensing deals and M&A transactions as well as strategic projects for

Read More...

Assaf Barnea

Assaf Barnea

CEO of Sanara Ventures

Mr. Assaf Barnea, CEO of Sanara Ventures is a seasoned entrepreneur and venture professional with significant multidisciplinary experience in building innovation platforms and commercialization processes in healthcare and Cleantech. Sanara Ventures is a healthcare investment platform, jointly held by Teva Pharmaceuticals and Philips Healthcare. Assaf is also a business consultant at the World bank/IFC venture

Read More...

Eyal Fruchter, MD

Eyal Fruchter, MD

Head of the Psychiatric Ward, Rambam Medical center

Eyal Fruchter, is a Psychiatrist, currently the head of the psychiatric ward in Rambam Medical center. He graduated from the Technion in Haifa, and than started his military service as a field doctor and a flight surgeon. After 5 years of service, went to specialize in psychiatry, and served as the head of psychology branch in the

Read More...

Eyal Baror

Eyal Baror

CEO and President of Neuronix Ltd.

Eyal Baror is the CEO and President of Neuronix Ltd., which developed the first medical device for the treatment of Alzheimer’s Disease. Eyal has been leading Neuronix since 2009, starting with the early scientific concept, developing Neuronix therapy system, demonstrating its efficacy through series of rigorous clinical studies, obtaining regulatory approvals and launching commercial activity.

Read More...

Melanie Leitner, PhD

Melanie Leitner, PhD

Founder of Accelerating NeuroVentures, LLC

Dr. Melanie Leitner is the Founder of Accelerating NeuroVentures, LLC, a solo consulting practice providing strategic, programmatic, and business development services to investors, biopharma, and non-profit clients interested in funding, initiating, or advancing programs within the neuroscience translational space. Her clients have included SV Life Sciences, the XPRIZE Foundation, the ALS Investment Fund, Clearview Healthcare Partners, the Center

Read More...

Ross D. Zafonte, MD

Ross D. Zafonte, MD

Professor and Chairman of the Department of Physical Medicine and Rehabilitation at Harvard Medical School

Dr. Ross D. Zafonte is Earle P. and Ida S. Charlton Professor and Chairman of the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He also serves as chief of Physical Medicine and Rehabilitation at Massachusetts General Hospital, as well as Vice President Medical Affairs Research and Education at Spaulding Rehabilitation Network. Dr. Zafonte’s textbook is considered

Read More...

Yael Fuchs Shlomai, PhD

Yael Fuchs Shlomai, PhD

Director, Startup Programs, IBT

Yael holds a PhD in Neuroscience. During her studies, she has received numerous awards for academic excellence and published several papers in leading scientific journals. Yael holds a BA in both Psychology and Biology, graduating Summa Cum Laude from the Hebrew University of Jerusalem.  With vast experience in content development, Yael previously served as scientific content

Read More...

Rafi Gidron, PhD

Rafi Gidron, PhD

Founder and Chairman, Israel Brain Technologies

Dr. Rafi Gidron is an entrepreneur who founded and managed technology companies in multiple disciplines including fields such as telecommunications, nanotechnology, neurotechnology and cleantech. Most notably, Gidron was involved in one of the most successful exits in Israel’s hi-tech industry: the acquisition of Chromatis Networks by Lucent in 2000. Gidron serves as the founder and chairman

Read More...

Nechemia (Chemi) J. Peres

Nechemia (Chemi) J. Peres

Managing General Partner and Co-Founder of Pitango

Chemi Peres is a pioneer in the Venture Capital industry in Israel. He is Managing General Partner and Co-Founder of Pitango, Israel’s leading Venture Capital Group with over $2 Billion under management, and a portfolio of some 230 high tech companies. Currently he serves on the boards of numerous Pitango portfolio companies such as Taboola,

Read More...

Yair Bar-Haim, PhD

Yair Bar-Haim, PhD

Professor of Psychology and Neuroscience at Tel Aviv University

Yair Bar-Haim is Professor of Psychology and Neuroscience at Tel Aviv University, director of the University’s Adler Center for Development and Psychopathology and the Laboratory for Research on Anxiety and Trauma. Prof. Bar-Haim’s research focuses on emotional, cognitive, neural, and genetic mechanisms underlying anxiety and anxiety disorders, with a particular emphasis on social anxiety and post-traumatic

Read More...

Nava Levit Binnun, PhD

Nava Levit Binnun, PhD

Head of the Sagol Center for Brain and Mind at the Interdisciplinary Center (IDC) Herzliya, Israel

Dr. Nava Levit Binnun is a neuroscientist heading the Sagol Center for Brain and Mind at the Interdisciplinary Center (IDC) Herzliya. Her research focuses on understanding resilience-building mechanism such as the role of interpersonal interactions and mindfulness training. Her lab is also involved in developing EEG and EEG-TMS based methods for identifying indicators of vulnerability

Read More...

Miri Polachek

Miri Polachek

Executive Director, Israel Brain Technologies

Miri Polachek is an Israeli-American with 20 years of experience and passion in the life sciences sector. She held financial management positions at Teva Pharmaceuticals in Israel and at Pfizer in New York and served as VP Finance at IntegraMed America, specialty healthcare services firm. After more than a decade in New York, Miri moved

Read More...
Developed By Razztech
Menu